The associate chief medical officer at Michigan State University highlighted advances in neuromuscular disease, emerging therapeutic strategies, and the growing role of patient-reported outcomes at AANEM 2025. [WATCH TIME: 2 minutes]
Amit Sachdev, MD, MS
Advertisement
Articles by Amit Sachdev, MD, MS
Expert discusses individualized treatment strategies that balance efficacy, tolerability, and lifestyle considerations to move patients beyond maintenance plateaus in CIDP care.
Expert discusses how CIDP clinical trials have progressed toward patient-focused designs that strengthen scientific rigor while safeguarding participants.
Expert discusses the clinical reasoning, electrophysiologic tools, and consensus criteria that underpin accurate diagnosis and differentiation of CIDP from other neuropathies.
Advertisement
Latest Updated Articles
Evolution of CIDP Clinical Trials and Patient ProtectionPublished: November 13th 2025 | Updated:
- Ensuring a Comprehensive Diagnosis of CIDP and the Role of EMG
Published: November 6th 2025 | Updated:
- Optimizing Treatment Selection and Moving Beyond the Plateau
Published: November 20th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Late-Breaking CHOICE 2 Data Indicate Alteplase Displayed Improved Stroke Recovery
2
Women Physicians Day 2026: Sex-Specific Clinical Considerations in Women With Epilepsy
3
Biomarker Data Across Studies Support Disease-Targeted Effects of Valiltramiprosate
4
NeuroVoices: Benjamin Tolchin, MD, FAAN, on First-Ever AAN Guidelines for Functional Seizures
5